National Engineering Research Center for Beijing Biochip Technology, Changping District, Beijing, China.
J Clin Microbiol. 2010 Oct;48(10):3654-60. doi: 10.1128/JCM.00158-10. Epub 2010 Aug 4.
The accurate detection of mycobacterial species from isolates and clinical samples is important for pathogenic diagnosis and treatment and for disease control. There is an urgent need for the development of a rapid, simple, and accurate detection method. We established a biochip assay system, including a biochip, sample preparation apparatus, hybridization instrument, chip washing machine, and laser confocal scanner equipped with interpretation software for automatic diagnosis. The biochip simultaneously identified 17 common mycobacterial species by targeting the differences in the 16S rRNA. The system was assessed with 64 reference strains and 296 Mycobacterium tuberculosis and 243 nontuberculous mycobacterial isolates, as well as 138 other bacteria and 195 sputum samples, and then compared to DNA sequencing. The entire biochip assay took 6 h. The concordance rate between the biochip assay and the DNA sequencing results was 100%. In conclusion, the biochip system provides a simple, rapid, reliable, and highly accurate clinical assay for determination of mycobacterial species in a 6-h procedure, from either culture isolates or sputum samples, allowing earlier pathogen-adapted antimicrobial therapy in patients.
准确检测分离株和临床样本中的分枝杆菌菌种对于病原诊断和治疗以及疾病控制非常重要。因此,迫切需要开发一种快速、简单、准确的检测方法。我们建立了一种生物芯片检测系统,包括生物芯片、样品制备装置、杂交仪器、芯片清洗机和配备自动诊断解读软件的激光共聚焦扫描仪。该生物芯片通过针对 16S rRNA 的差异同时鉴定了 17 种常见分枝杆菌菌种。该系统用 64 株参考菌株、296 株结核分枝杆菌和 243 株非结核分枝杆菌分离株以及 138 株其他细菌和 195 份痰标本进行了评估,然后与 DNA 测序进行了比较。整个生物芯片检测耗时 6 小时。生物芯片检测与 DNA 测序结果的一致性为 100%。总之,该生物芯片系统为从培养物或痰标本中确定分枝杆菌菌种提供了一种简单、快速、可靠和高度准确的临床检测方法,可使患者更早地进行针对病原体的抗菌治疗。